{"id": "article-17077_0", "title": "Acetazolamide -- Continuing Education Activity", "content": "Acetazolamide is a diuretic and carbonic anhydrase inhibitor medication used to treat several illnesses. It works to cause an accumulation of carbonic acid by preventing its breakdown. FDA-approved indications include glaucoma, idiopathic intracranial hypertension, congestive heart failure, altitude sickness, periodic paralysis, and epilepsy. In addition, it is used off-label for central sleep apnea, Marfan syndrome, prevention of high-dose methotrexate nephrotoxicity, and prevention of contrast-induced nephropathy. This activity outlines the indications, contraindications, interactions, monitoring, and other therapeutic information pertinent to members of an interprofessional team in the care of patients with conditions requiring the use of acetazolamide.", "contents": "Acetazolamide -- Continuing Education Activity. Acetazolamide is a diuretic and carbonic anhydrase inhibitor medication used to treat several illnesses. It works to cause an accumulation of carbonic acid by preventing its breakdown. FDA-approved indications include glaucoma, idiopathic intracranial hypertension, congestive heart failure, altitude sickness, periodic paralysis, and epilepsy. In addition, it is used off-label for central sleep apnea, Marfan syndrome, prevention of high-dose methotrexate nephrotoxicity, and prevention of contrast-induced nephropathy. This activity outlines the indications, contraindications, interactions, monitoring, and other therapeutic information pertinent to members of an interprofessional team in the care of patients with conditions requiring the use of acetazolamide."}
{"id": "article-17077_1", "title": "Acetazolamide -- Continuing Education Activity", "content": "Objectives: Identify the indications for acetazolamide, both FDA-approved and off-label. Describe the mechanism of action of acetazolamide. Summarize the adverse event profile of acetazolamide. Explain the importance of collaboration and coordination among the interprofessional team and how it can enhance patient care with acetazolamide therapy to improve patient outcomes for patients with indicated conditions. Access free multiple choice questions on this topic.", "contents": "Acetazolamide -- Continuing Education Activity. Objectives: Identify the indications for acetazolamide, both FDA-approved and off-label. Describe the mechanism of action of acetazolamide. Summarize the adverse event profile of acetazolamide. Explain the importance of collaboration and coordination among the interprofessional team and how it can enhance patient care with acetazolamide therapy to improve patient outcomes for patients with indicated conditions. Access free multiple choice questions on this topic."}
{"id": "article-17077_2", "title": "Acetazolamide -- Indications", "content": "Acetazolamide is a diuretic and carbonic anhydrase inhibitor medication used to treat several illnesses, as\u00a0summarized\u00a0below. [1]", "contents": "Acetazolamide -- Indications. Acetazolamide is a diuretic and carbonic anhydrase inhibitor medication used to treat several illnesses, as\u00a0summarized\u00a0below. [1]"}
{"id": "article-17077_3", "title": "Acetazolamide -- Indications -- FDA-approved Indications", "content": "Glaucoma [2] Idiopathic intracranial hypertension [3] Congestive heart failure [4] Altitude sickness [5] Periodic paralysis [6] Epilepsy [7]", "contents": "Acetazolamide -- Indications -- FDA-approved Indications. Glaucoma [2] Idiopathic intracranial hypertension [3] Congestive heart failure [4] Altitude sickness [5] Periodic paralysis [6] Epilepsy [7]"}
{"id": "article-17077_4", "title": "Acetazolamide -- Indications -- Non-FDA-approved Indications", "content": "Central sleep apnea [8] Marfan syndrome [9] Prevention of high-dose methotrexate\u00a0nephrotoxicity [10] Prevention of contrast-induced nephropathy [11]", "contents": "Acetazolamide -- Indications -- Non-FDA-approved Indications. Central sleep apnea [8] Marfan syndrome [9] Prevention of high-dose methotrexate\u00a0nephrotoxicity [10] Prevention of contrast-induced nephropathy [11]"}
{"id": "article-17077_5", "title": "Acetazolamide -- Indications", "content": "Acetazolamide is a classic treatment option for glaucoma as it causes a reduction in aqueous humor. It is also useful for treating altitude sickness because of its underlying mechanism of action. The medication works to excrete bicarbonate. Doing so alkalizes the urine as there is greater bicarbonate in the urine. As a result, the blood is more acidic, given that the bicarbonate has been excreted. Some mechanisms equate the carbon dioxide concentrations in the body to the degree of acidity, resulting in an artificial compensatory mechanism for what the body believes to be excess carbon dioxide. This compensation results in faster and deeper breathing. The outcome of that is higher oxygen concentrations in the body, which improves the ability of the body to adjust itself to the higher altitude levels. [12]", "contents": "Acetazolamide -- Indications. Acetazolamide is a classic treatment option for glaucoma as it causes a reduction in aqueous humor. It is also useful for treating altitude sickness because of its underlying mechanism of action. The medication works to excrete bicarbonate. Doing so alkalizes the urine as there is greater bicarbonate in the urine. As a result, the blood is more acidic, given that the bicarbonate has been excreted. Some mechanisms equate the carbon dioxide concentrations in the body to the degree of acidity, resulting in an artificial compensatory mechanism for what the body believes to be excess carbon dioxide. This compensation results in faster and deeper breathing. The outcome of that is higher oxygen concentrations in the body, which improves the ability of the body to adjust itself to the higher altitude levels. [12]"}
{"id": "article-17077_6", "title": "Acetazolamide -- Mechanism of Action", "content": "Acetazolamide is a carbonic anhydrase inhibitor. That means this drug works to cause an accumulation of carbonic acid by preventing its breakdown. The result is lower blood pH (i.e., more acidic), given the increased carbonic acid, which has a reversible reaction into bicarbonate and a hydrogen ion.", "contents": "Acetazolamide -- Mechanism of Action. Acetazolamide is a carbonic anhydrase inhibitor. That means this drug works to cause an accumulation of carbonic acid by preventing its breakdown. The result is lower blood pH (i.e., more acidic), given the increased carbonic acid, which has a reversible reaction into bicarbonate and a hydrogen ion."}
{"id": "article-17077_7", "title": "Acetazolamide -- Mechanism of Action", "content": "Carbonic\u00a0anhydrase is found in the proximal tubule of the\u00a0nephron and red blood cells. It works to reabsorb sodium, bicarbonate, and chloride. Once acetazolamide inhibits carbonic anhydrase, sodium, bicarbonate, and chloride get excreted rather than reabsorbed; this also leads to the excretion of excess water. The clinical result is a decrease in blood pressure, decreased intracranial pressure, and decreased intraocular pressure. Bicarbonate excretion also increases the acidity of the blood. Aqueous humor levels decrease in the eyes, and there are compensatory mechanisms for increased blood acidity, for example, hyperventilation.", "contents": "Acetazolamide -- Mechanism of Action. Carbonic\u00a0anhydrase is found in the proximal tubule of the\u00a0nephron and red blood cells. It works to reabsorb sodium, bicarbonate, and chloride. Once acetazolamide inhibits carbonic anhydrase, sodium, bicarbonate, and chloride get excreted rather than reabsorbed; this also leads to the excretion of excess water. The clinical result is a decrease in blood pressure, decreased intracranial pressure, and decreased intraocular pressure. Bicarbonate excretion also increases the acidity of the blood. Aqueous humor levels decrease in the eyes, and there are compensatory mechanisms for increased blood acidity, for example, hyperventilation."}
{"id": "article-17077_8", "title": "Acetazolamide -- Mechanism of Action", "content": "The entire process of excretion inhibited by carbonic anhydrase is essentially\u00a0working to acidify the urine and reabsorb bicarbonate. Acetazolamide will derange the whole process by increasing sodium in the urine and increasing bicarbonate which alkalinizes the urine. Diuresis is the other result. [12]", "contents": "Acetazolamide -- Mechanism of Action. The entire process of excretion inhibited by carbonic anhydrase is essentially\u00a0working to acidify the urine and reabsorb bicarbonate. Acetazolamide will derange the whole process by increasing sodium in the urine and increasing bicarbonate which alkalinizes the urine. Diuresis is the other result. [12]"}
{"id": "article-17077_9", "title": "Acetazolamide -- Mechanism of Action", "content": "In the eye, the inhibitory activity of acetazolamide reduces the secretion of aqueous humor resulting in a reduction in intraocular pressure, which is beneficial for glaucoma.\u00a0Acetazolamide is also used in treating idiopathic intracranial hypertension, as it inhibits enzymes in the choroid plexus and reduces the production of CSF, resulting in a decrease in intracranial pressure(ICP). [13]", "contents": "Acetazolamide -- Mechanism of Action. In the eye, the inhibitory activity of acetazolamide reduces the secretion of aqueous humor resulting in a reduction in intraocular pressure, which is beneficial for glaucoma.\u00a0Acetazolamide is also used in treating idiopathic intracranial hypertension, as it inhibits enzymes in the choroid plexus and reduces the production of CSF, resulting in a decrease in intracranial pressure(ICP). [13]"}
{"id": "article-17077_10", "title": "Acetazolamide -- Mechanism of Action", "content": "In epilepsy, inhibition of carbonic anhydrase by acetazolamide seems to retard abnormal, excessive, paroxysmal electrical discharge from neurons.\u00a0Carbonic anhydrase expression is extensively detected in CNS. Carbonic anhydrase inhibitor acetazolamide affects the delicate equilibrium among CO2, H+, and HCO3- in the\u00a0neurons and modulates the activity of ligand-gated ion channels at the neuronal level, such as GABA-A signaling. In addition, studies report their capacity to modulate Ca2+ kinetics through ligand-gated Ca2+ channels and voltage-gated Ca2+ channels (VGCC).\u00a0Carbonic anhydrases rapidly decrease or increase H+ and HCO3 \u2212 in the neurons. Acetazolamide modulates the abnormal GABA-A-mediated depolarization that generates epileptic waves and has been shown to block epileptiform activity by inhibiting HCO3 -efflux. The integration of the above-illustrated\u00a0mechanisms may\u00a0explain\u00a0the antiepileptic effect of acetazolamide. [14]", "contents": "Acetazolamide -- Mechanism of Action. In epilepsy, inhibition of carbonic anhydrase by acetazolamide seems to retard abnormal, excessive, paroxysmal electrical discharge from neurons.\u00a0Carbonic anhydrase expression is extensively detected in CNS. Carbonic anhydrase inhibitor acetazolamide affects the delicate equilibrium among CO2, H+, and HCO3- in the\u00a0neurons and modulates the activity of ligand-gated ion channels at the neuronal level, such as GABA-A signaling. In addition, studies report their capacity to modulate Ca2+ kinetics through ligand-gated Ca2+ channels and voltage-gated Ca2+ channels (VGCC).\u00a0Carbonic anhydrases rapidly decrease or increase H+ and HCO3 \u2212 in the neurons. Acetazolamide modulates the abnormal GABA-A-mediated depolarization that generates epileptic waves and has been shown to block epileptiform activity by inhibiting HCO3 -efflux. The integration of the above-illustrated\u00a0mechanisms may\u00a0explain\u00a0the antiepileptic effect of acetazolamide. [14]"}
{"id": "article-17077_11", "title": "Acetazolamide -- Mechanism of Action -- Pharmacokinetics", "content": "Absorption: Well absorbed", "contents": "Acetazolamide -- Mechanism of Action -- Pharmacokinetics. Absorption: Well absorbed"}
{"id": "article-17077_12", "title": "Acetazolamide -- Mechanism of Action -- Pharmacokinetics", "content": "Distribution: Carbonic anhydrase inhibitors such as acetazolamide are avidly bound by carbonic anhydrase; consequently, tissues rich in enzymes, such as kidneys and RBC, will have higher concentrations of carbonic anhydrase inhibitors (acetazolamide) Metabolism: Acetazolamide does not undergo metabolic alteration. Excretion: Plasma half-Life: 6-9 hours; renal excretion is the primary route of elimination.", "contents": "Acetazolamide -- Mechanism of Action -- Pharmacokinetics. Distribution: Carbonic anhydrase inhibitors such as acetazolamide are avidly bound by carbonic anhydrase; consequently, tissues rich in enzymes, such as kidneys and RBC, will have higher concentrations of carbonic anhydrase inhibitors (acetazolamide) Metabolism: Acetazolamide does not undergo metabolic alteration. Excretion: Plasma half-Life: 6-9 hours; renal excretion is the primary route of elimination."}
{"id": "article-17077_13", "title": "Acetazolamide -- Administration", "content": "Patients take acetazolamide with or without food and should drink plenty of fluids with the medication. Available dosages are 125 mg, 250 mg, and 500 mg tablets. [15] These are also available in instant-release\u00a0and extended-release drug dosage forms. Intravenous (IV) administration of acetazolamide is available. However, intramuscular (IM) administration of acetazolamide\u00a0is not recommended.", "contents": "Acetazolamide -- Administration. Patients take acetazolamide with or without food and should drink plenty of fluids with the medication. Available dosages are 125 mg, 250 mg, and 500 mg tablets. [15] These are also available in instant-release\u00a0and extended-release drug dosage forms. Intravenous (IV) administration of acetazolamide is available. However, intramuscular (IM) administration of acetazolamide\u00a0is not recommended."}
{"id": "article-17077_14", "title": "Acetazolamide -- Administration", "content": "The dose range recommended for the treatment of glaucoma is 250 mg per day to 1000 mg per day. Typically, the dose will be 250 to 500 mg per day. For treating altitude sickness, the range is 250 to 500 mg daily in 2 oral doses. [15] Lower doses are recommended when treating edema, epilepsy, and diuresis in congestive heart failure. The range used for those conditions is usually 250 to 375 mg. However, epilepsy may require higher dosages, up to 1000 mg daily.", "contents": "Acetazolamide -- Administration. The dose range recommended for the treatment of glaucoma is 250 mg per day to 1000 mg per day. Typically, the dose will be 250 to 500 mg per day. For treating altitude sickness, the range is 250 to 500 mg daily in 2 oral doses. [15] Lower doses are recommended when treating edema, epilepsy, and diuresis in congestive heart failure. The range used for those conditions is usually 250 to 375 mg. However, epilepsy may require higher dosages, up to 1000 mg daily."}
{"id": "article-17077_15", "title": "Acetazolamide -- Administration -- Use in Specific Patient Population", "content": "Patients with Renal Impairment: Use is not recommended in\u00a0cases of marked kidney disease. Patients with Hepatic Impairment: Acetazolamide is\u00a0contraindicated in cirrhosis because of the risk of developing hepatic encephalopathy.", "contents": "Acetazolamide -- Administration -- Use in Specific Patient Population. Patients with Renal Impairment: Use is not recommended in\u00a0cases of marked kidney disease. Patients with Hepatic Impairment: Acetazolamide is\u00a0contraindicated in cirrhosis because of the risk of developing hepatic encephalopathy."}
{"id": "article-17077_16", "title": "Acetazolamide -- Administration -- Use in Specific Patient Population", "content": "Pregnancy Considerations: The use\u00a0of acetazolamide in\u00a0pregnancy\u00a0has not been recommended because of teratogenic effects in\u00a0preclinical studies.\u00a0But\u00a0in a study of pregnant patients with idiopathic intracranial hypertension,\u00a0no conclusive evidence of the adverse effects of acetazolamide during pregnancy was observed. [16] Acetazolamide was a Category C drug under the prior FDA pregnancy categorization system and should only be used in pregnancy if the benefits outweigh the risks to the unborn baby. Consequently, clinicians should\u00a0prescribe\u00a0acetazolamide only when indicated.", "contents": "Acetazolamide -- Administration -- Use in Specific Patient Population. Pregnancy Considerations: The use\u00a0of acetazolamide in\u00a0pregnancy\u00a0has not been recommended because of teratogenic effects in\u00a0preclinical studies.\u00a0But\u00a0in a study of pregnant patients with idiopathic intracranial hypertension,\u00a0no conclusive evidence of the adverse effects of acetazolamide during pregnancy was observed. [16] Acetazolamide was a Category C drug under the prior FDA pregnancy categorization system and should only be used in pregnancy if the benefits outweigh the risks to the unborn baby. Consequently, clinicians should\u00a0prescribe\u00a0acetazolamide only when indicated."}
{"id": "article-17077_17", "title": "Acetazolamide -- Administration -- Use in Specific Patient Population", "content": "Breastfeeding Considerations: Data suggests that maternal doses of acetazolamide up to 1000 mg daily deliver low levels in milk and would not be anticipated to cause any adverse effects in breastfed infants. In addition, various international professional\u00a0guidelines consensus that carbonic anhydrase inhibitors such as acetazolamide are acceptable in breastfeeding. [17]", "contents": "Acetazolamide -- Administration -- Use in Specific Patient Population. Breastfeeding Considerations: Data suggests that maternal doses of acetazolamide up to 1000 mg daily deliver low levels in milk and would not be anticipated to cause any adverse effects in breastfed infants. In addition, various international professional\u00a0guidelines consensus that carbonic anhydrase inhibitors such as acetazolamide are acceptable in breastfeeding. [17]"}
{"id": "article-17077_18", "title": "Acetazolamide -- Adverse Effects", "content": "There is a broad range of general and specific adverse effects that acetazolamide use can induce. Fatigue, nausea, vomiting, abdominal pain, and diarrhea\u00a0are common in patients. Other patients will experience paresthesia, black stools, decreased libido, tinnitus, and taste alteration. There are also reports of patients developing depression while using acetazolamide or developing a bitter or metallic taste. Less commonly, there is a risk of developing metabolic acidosis, hyponatremia, and hypokalemia. Kidney stones can also be seen but are uncommon. Occasionally, patients develop Stevens-Johnson syndrome, aplastic anemia, agranulocytosis, toxic epidermal necrolysis, or fulminant hepatic necrosis. [18]", "contents": "Acetazolamide -- Adverse Effects. There is a broad range of general and specific adverse effects that acetazolamide use can induce. Fatigue, nausea, vomiting, abdominal pain, and diarrhea\u00a0are common in patients. Other patients will experience paresthesia, black stools, decreased libido, tinnitus, and taste alteration. There are also reports of patients developing depression while using acetazolamide or developing a bitter or metallic taste. Less commonly, there is a risk of developing metabolic acidosis, hyponatremia, and hypokalemia. Kidney stones can also be seen but are uncommon. Occasionally, patients develop Stevens-Johnson syndrome, aplastic anemia, agranulocytosis, toxic epidermal necrolysis, or fulminant hepatic necrosis. [18]"}
{"id": "article-17077_19", "title": "Acetazolamide -- Adverse Effects", "content": "Common side effects of this medication include fatigue, abdominal pain, nausea, vomiting, and paresthesia. Rare side effects, such as Stevens-Johnson syndrome, also exist. The drug can be administered orally as well as via the intravascular route. It should not be used by those with impaired renal or hepatic function. The medication is also known to interact with certain antibiotics, sodium bicarbonate, amphetamines, and salicylates. [19]", "contents": "Acetazolamide -- Adverse Effects. Common side effects of this medication include fatigue, abdominal pain, nausea, vomiting, and paresthesia. Rare side effects, such as Stevens-Johnson syndrome, also exist. The drug can be administered orally as well as via the intravascular route. It should not be used by those with impaired renal or hepatic function. The medication is also known to interact with certain antibiotics, sodium bicarbonate, amphetamines, and salicylates. [19]"}
{"id": "article-17077_20", "title": "Acetazolamide -- Contraindications", "content": "Since acetazolamide decreases the clearance of ammonia, patients with impaired liver function or liver disease should not use acetazolamide. [20] Usage may precipitate the development of hepatic encephalopathy.", "contents": "Acetazolamide -- Contraindications. Since acetazolamide decreases the clearance of ammonia, patients with impaired liver function or liver disease should not use acetazolamide. [20] Usage may precipitate the development of hepatic encephalopathy."}
{"id": "article-17077_21", "title": "Acetazolamide -- Contraindications", "content": "Acetazolamide can induce electrolyte abnormalities. As such,\u00a0those with\u00a0hypokalemia or hyponatremia should not use it. Similarly,\u00a0it can decrease kidney function, and clinicians should avoid using it with anyone with kidney disease or decreased kidney function. Patients with hyperchloremic acidosis should not use acetazolamide. [21]", "contents": "Acetazolamide -- Contraindications. Acetazolamide can induce electrolyte abnormalities. As such,\u00a0those with\u00a0hypokalemia or hyponatremia should not use it. Similarly,\u00a0it can decrease kidney function, and clinicians should avoid using it with anyone with kidney disease or decreased kidney function. Patients with hyperchloremic acidosis should not use acetazolamide. [21]"}
{"id": "article-17077_22", "title": "Acetazolamide -- Contraindications", "content": "Although acetazolamide does not cause prolongation of the QTc interval, those with prolonged QTc should use it cautiously and have their potassium concentrations monitored, given the drug's ability to cause hypokalemia. Patients with an allergy to sulfonamides (e.g., sulfa allergy) should not use acetazolamide. [22] [21]", "contents": "Acetazolamide -- Contraindications. Although acetazolamide does not cause prolongation of the QTc interval, those with prolonged QTc should use it cautiously and have their potassium concentrations monitored, given the drug's ability to cause hypokalemia. Patients with an allergy to sulfonamides (e.g., sulfa allergy) should not use acetazolamide. [22] [21]"}
{"id": "article-17077_23", "title": "Acetazolamide -- Contraindications", "content": "Acetazolamide\u00a0is known\u00a0to interact with several classes of medications. A patient on amphetamines will likely develop reduced amphetamine clearance because acetazolamide increases the urine pH. In contrast, it increases the excretion of lithium, and hence its efficacy may be reduced. Acetazolamide also decreases the excretion of phenytoin, primidone, and quinidine. Patients on these medications may develop toxicity if they also use acetazolamide concurrently. [23] [24]", "contents": "Acetazolamide -- Contraindications. Acetazolamide\u00a0is known\u00a0to interact with several classes of medications. A patient on amphetamines will likely develop reduced amphetamine clearance because acetazolamide increases the urine pH. In contrast, it increases the excretion of lithium, and hence its efficacy may be reduced. Acetazolamide also decreases the excretion of phenytoin, primidone, and quinidine. Patients on these medications may develop toxicity if they also use acetazolamide concurrently. [23] [24]"}
{"id": "article-17077_24", "title": "Acetazolamide -- Contraindications", "content": "Patients on salicylates can develop toxicity if they begin acetazolamide. In addition, patients on sodium bicarbonate therapy have an increased risk of nephrolithiasis if using acetazolamide simultaneously.", "contents": "Acetazolamide -- Contraindications. Patients on salicylates can develop toxicity if they begin acetazolamide. In addition, patients on sodium bicarbonate therapy have an increased risk of nephrolithiasis if using acetazolamide simultaneously."}
{"id": "article-17077_25", "title": "Acetazolamide -- Contraindications", "content": "Patients using anti-folates, including methotrexate and trimethoprim, should not use acetazolamide.\u00a0Also, patients on any other carbonic anhydrase inhibitor should avoid this medication. Patients with a previous history of developing a serious rash should avoid the usage of acetazolamide as it can induce Stevens-Johnson syndrome. [25]", "contents": "Acetazolamide -- Contraindications. Patients using anti-folates, including methotrexate and trimethoprim, should not use acetazolamide.\u00a0Also, patients on any other carbonic anhydrase inhibitor should avoid this medication. Patients with a previous history of developing a serious rash should avoid the usage of acetazolamide as it can induce Stevens-Johnson syndrome. [25]"}
{"id": "article-17077_26", "title": "Acetazolamide -- Monitoring", "content": "CBC and platelet counts are obtained on patients\u00a0at initiation of acetazolamide therapy and at regular intervals during therapy as acetazolamide is a sulfa drug. If\u00a0there is a significant change from the baseline,\u00a0discontinue the therapy. It is also recommended to monitor\u00a0serum electrolytes\u00a0periodically. [26]", "contents": "Acetazolamide -- Monitoring. CBC and platelet counts are obtained on patients\u00a0at initiation of acetazolamide therapy and at regular intervals during therapy as acetazolamide is a sulfa drug. If\u00a0there is a significant change from the baseline,\u00a0discontinue the therapy. It is also recommended to monitor\u00a0serum electrolytes\u00a0periodically. [26]"}
{"id": "article-17077_27", "title": "Acetazolamide -- Toxicity", "content": "There have been reports of central nervous system (CNS) toxicity with coma. [27] In addition, hyperchloremic metabolic acidosis and electrolyte disturbances are usually seen in acetazolamide overdose. Therefore, clinicians should rapidly obtain serum electrolyte levels (especially serum potassium) and arterial blood gas analysis.\u00a0According to\u00a0product\u00a0labeling, there is no specific antidote to acetazolamide; hence treatment is usually supportive. Bicarbonate administration can usually correct metabolic acidosis. Despite its plasma protein binding and high RBC distribution, acetazolamide may be dialyzable. Dialysis may be especially valuable in managing acetazolamide overdosage complicated with acute kidney injury.", "contents": "Acetazolamide -- Toxicity. There have been reports of central nervous system (CNS) toxicity with coma. [27] In addition, hyperchloremic metabolic acidosis and electrolyte disturbances are usually seen in acetazolamide overdose. Therefore, clinicians should rapidly obtain serum electrolyte levels (especially serum potassium) and arterial blood gas analysis.\u00a0According to\u00a0product\u00a0labeling, there is no specific antidote to acetazolamide; hence treatment is usually supportive. Bicarbonate administration can usually correct metabolic acidosis. Despite its plasma protein binding and high RBC distribution, acetazolamide may be dialyzable. Dialysis may be especially valuable in managing acetazolamide overdosage complicated with acute kidney injury."}
{"id": "article-17077_28", "title": "Acetazolamide -- Enhancing Healthcare Team Outcomes", "content": "Acetazolamide is not frequently used in clinical medicine, but clinicians need to know\u00a0the drug's adverse effects and contraindications. Patients require education from the team, including the clinician, nurse, and pharmacist, on the dose and indications of the drug and to report any side effects. Because there is no antidote to acetazolamide, it is essential to emphasize to the patient to seek immediate care if there is an overdose. The prescriber should work with the pharmacist on medication reconciliation to ensure no drug-drug interactions.\u00a0The prescriber should also use Tall Man (mixed case) lettering for the prescription of acetazolamide which is included in\u00a0look-alike-sound-alike drugs. [11]", "contents": "Acetazolamide -- Enhancing Healthcare Team Outcomes. Acetazolamide is not frequently used in clinical medicine, but clinicians need to know\u00a0the drug's adverse effects and contraindications. Patients require education from the team, including the clinician, nurse, and pharmacist, on the dose and indications of the drug and to report any side effects. Because there is no antidote to acetazolamide, it is essential to emphasize to the patient to seek immediate care if there is an overdose. The prescriber should work with the pharmacist on medication reconciliation to ensure no drug-drug interactions.\u00a0The prescriber should also use Tall Man (mixed case) lettering for the prescription of acetazolamide which is included in\u00a0look-alike-sound-alike drugs. [11]"}
{"id": "article-17077_29", "title": "Acetazolamide -- Enhancing Healthcare Team Outcomes", "content": "Pharmacists should also verify that the prescription\u00a0as acetazolamide is included in the ISMP (Institute for Safe Medication Practices) medication list to avoid confusion. [28] The nurse should be able to monitor the patient on subsequent visits, counsel on medication administration, and verify patient adherence. Nursing is often a bridge between the prescriber, pharmacist, and other clinicians. All interprofessional team members must document their findings in the patient's record whenever they interact with them. They are also responsible for\u00a0communicating to the appropriate team members if any changes in the patient's status may merit attention. The interprofessional healthcare team can optimize therapy with acetazolamide while minimizing adverse events, resulting in better therapeutic outcomes for the patient. [Level 5]", "contents": "Acetazolamide -- Enhancing Healthcare Team Outcomes. Pharmacists should also verify that the prescription\u00a0as acetazolamide is included in the ISMP (Institute for Safe Medication Practices) medication list to avoid confusion. [28] The nurse should be able to monitor the patient on subsequent visits, counsel on medication administration, and verify patient adherence. Nursing is often a bridge between the prescriber, pharmacist, and other clinicians. All interprofessional team members must document their findings in the patient's record whenever they interact with them. They are also responsible for\u00a0communicating to the appropriate team members if any changes in the patient's status may merit attention. The interprofessional healthcare team can optimize therapy with acetazolamide while minimizing adverse events, resulting in better therapeutic outcomes for the patient. [Level 5]"}
{"id": "article-17077_30", "title": "Acetazolamide -- Review Questions", "content": "Access free multiple choice questions on this topic. Comment on this article.", "contents": "Acetazolamide -- Review Questions. Access free multiple choice questions on this topic. Comment on this article."}